Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Relationship between Working Hours and Power of Attention, Memory, Fatigue, Depression and Self-Efficacy One Year after Diagnosis of Clinically Isolated Syndrome and Relapsing Remitting Multiple Sclerosis.
Multiple Sclerosis: Improved Identification of Disease-relevant Changes in Gray and White Matter Using Susceptibility-based MR Imaging.
Anti-MOG antibodies in adult patients with demyelinating disorders of the central nervous system.
[Diet and multiple sclerosis].
Antiviral therapy of two patients with chromosomally-integrated human herpesvirus-6A presenting with cognitive dysfunction.
Autologous hematopoietic SCT normalizes miR-16, -155 and -142-3p expression in multiple sclerosis patients.
Health-related quality of life in relapsing remitting multiple sclerosis patients during treatment with glatiramer acetate: a prospective, observational, international, multi-centre study.
Progressive multifocal leukoencephalopathy: cavitary white matter lesions.
Medical and pharmacy claims-based algorithims for identifying patients with multiple sclerosis.
Quality of life in patients with multiple sclerosis.
Genetic aspects of vitamin D receptor and metabolism in relation to the risk of multiple sclerosis.
Crossreactivity of a human autoimmune TCR is dominated by a single TCR loop.
Self-Efficacy as a Predictor of Self-Reported Physical, Cognitive, and Social Functioning in Multiple Sclerosis.
Chemokines and chemokine receptors in multiple sclerosis.
Cognitive impairment in patients with multiple sclerosis predicts worse caregiver's health-related quality of life.
Mode of action and clinical studies with alemtuzumab.
Neuroinflammation and M2 microglia: the good, the bad, and the inflamed.
Contemporary treatment options for relapsing-remitting multiple sclerosis.
Regulatory B cells, helminths, and multiple sclerosis.
Cdk5 regulates developmental remodeling of mushroom body neurons in Drosophila.
Structural MRI substrates of cognitive impairment in neuromyelitis optica.
Epstein-Barr virus in systemic lupus erythematosus, rheumatoid arthritis and multiple sclerosis—association and causation.
Distinguishing Optic Neuritis in Neuromyelitis Optica Spectrum Disease From Multiple Sclerosis: A Novel Magnetic Resonance Imaging Scoring System.
On the Historical Succession of Vessel-Based Therapies in the Treatment of Multiple Sclerosis.
Knee muscle strength in multiple sclerosis: relationship with gait characteristics.
Pages
« first
‹ previous
…
382
383
384
385
386
387
388
389
390
…
next ›
last »